{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T13:20:03Z","timestamp":1773667203520,"version":"3.50.1"},"reference-count":43,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Office of Research and Development, The United States Department of Veterans Affairs as part of funding for VASeqCURE which in turn received funding from the American Rescue Plan Act funds and with additional support from Central Texas Veterans Health Care System, Temple, TX, USA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The SARS-CoV-2 virus steadily evolves, and numerous antigenically distinct variants have emerged over the past three years. Tracking the evolution of the virus would help us understand the process that generates the diverse variants and predict the future evolutionary trajectory of SARS-CoV-2. Here, we report the evolutionary trajectory of a unique Omicron lineage identified during an outbreak investigation that occurred in a residence unit in the healthcare system. The new lineage had four distinct non-synonymous and two distinct synonymous mutations apart from its parental lineage. Since this lineage of virus was exclusively found during the outbreak, we were able to track the detailed evolutionary history of the entire lineage along the transmission path. Furthermore, we estimated the evolutionary rate of the SARS-CoV-2 Omicron variant from the analysis of the evolution of the lineage. This new Omicron sub-lineage acquired 3 mutations in a 12-day period, and the evolutionary rate was estimated as 3.05 \u00d7 10\u22123 subs\/site\/year. This study provides more insight into an ever-evolving virus.<\/jats:p>","DOI":"10.3390\/v16030337","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T03:30:26Z","timestamp":1708572626000},"page":"337","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evolution of a Distinct SARS-CoV-2 Lineage Identified during an Investigation of a Hospital Outbreak"],"prefix":"10.3390","volume":"16","author":[{"given":"Hosoon","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Research, Central Texas Veterans Health Care System, Temple, TX 76504, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munok","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Research, Central Texas Veterans Health Care System, Temple, TX 76504, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Cornelius","sequence":"additional","affiliation":[{"name":"Department of Medicine, Central Texas Veterans Health Care System, Temple, TX 76504, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0070-5919","authenticated-orcid":false,"given":"Dhammika H.","family":"Navarathna","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Services, Central Texas Veterans Health Care System, Temple, TX 76504, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyali","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Research, Central Texas Veterans Health Care System, Temple, TX 76504, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Jinadatha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Central Texas Veterans Health Care System, Temple, TX 76504, USA"},{"name":"School of Medicine, Texas A&M University, Bryan, TX 77807, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10311-021-01318-4","article-title":"The viral phoenix: Enhanced infectivity and immunity evasion of SARS-CoV-2 variants","volume":"20","author":"Choi","year":"2022","journal-title":"Environ. Chem. Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jmv.27467","article-title":"Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19","volume":"94","author":"Kumar","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., Bhattacharya, M., Nag, S., Dhama, K., and Chakraborty, C. (2023). A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies. Viruses, 15.","DOI":"10.3390\/v15010167"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.21105\/joss.03773","article-title":"Nextclade: Clade assignment, mutation calling and quality control for viral genomes","volume":"6","author":"Aksamentov","year":"2021","journal-title":"J. Open Source Softw."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s Role in Pandemic Response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Choi, H., Hwang, M., Navarathna, D.H., Xu, J., Lukey, J., and Jinadatha, C. (2022). Performance of COVIDSeq and Swift Normalase Amplicon SARS-CoV-2 Panels for SARS-CoV-2 Genome Sequencing: Practical Guide and Combining FASTQ Strategy. J. Clin. Microbiol., 60.","DOI":"10.1128\/jcm.00025-22"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.csbj.2022.01.021","article-title":"Evidence of a SARS-CoV-2 double Spike mutation D614G\/S939F potentially affecting immune response of infected subjects","volume":"20","author":"Donzelli","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-022-00884-5","article-title":"Structural biology of SARS-CoV-2: Open the door for novel therapies","volume":"7","author":"Yan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mariano, G., Farthing, R.J., Lale-Farjat, S.L.M., and Bergeron, J.R.C. (2020). Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be. Front. Mol. Biosci., 7.","DOI":"10.3389\/fmolb.2020.605236"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/dna.2013.2304","article-title":"Untangling membrane rearrangement in the nidovirales","volume":"33","author":"Angelini","year":"2014","journal-title":"DNA Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12540","DOI":"10.1073\/pnas.0605402103","article-title":"Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release","volume":"103","author":"Lu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41422-021-00600-y","article-title":"Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2","volume":"32","author":"Zhang","year":"2022","journal-title":"Cell Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e2210990119","DOI":"10.1073\/pnas.2210990119","article-title":"Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e202201688","DOI":"10.26508\/lsa.202201688","article-title":"C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution","volume":"6","author":"Li","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sawyer, S.L., Emerman, M., and Malik, H.S. (2004). Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol., 2.","DOI":"10.1371\/journal.pbio.0020275"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature00939","article-title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein","volume":"418","author":"Sheehy","year":"2002","journal-title":"Nature"},{"key":"ref_19","first-page":"1029","article-title":"CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant","volume":"330","author":"Harris","year":"2023","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e29079","DOI":"10.1002\/jmv.29079","article-title":"On the SARS-CoV-2 BA.2.86 lineage: A mutation point of view","volume":"95","author":"Scarpa","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cell.2020.11.020","article-title":"Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity","volume":"184","author":"Volz","year":"2021","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"103589","DOI":"10.1016\/j.isci.2021.103589","article-title":"Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike","volume":"25","author":"Lubinski","year":"2022","journal-title":"iScience"},{"key":"ref_25","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41586-022-04835-6","article-title":"The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle","volume":"606","author":"Ricciardi","year":"2022","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2200592119","DOI":"10.1073\/pnas.2200592119","article-title":"Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles","volume":"119","author":"Syed","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Johnson, B.A., Zhou, Y., Lokugamage, K.G., Vu, M.N., Bopp, N., Crocquet-Valdes, P.A., Kalveram, B., Schindewolf, C., Liu, Y., and Scharton, D. (2022). Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1010627"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100480","DOI":"10.1016\/j.epidem.2021.100480","article-title":"Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland","volume":"37","author":"Chen","year":"2021","journal-title":"Epidemics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ofab328","DOI":"10.1093\/ofid\/ofab328","article-title":"Transmission of SARS-CoV-2 in Inpatient and Outpatient Settings in a Veterans Affairs Health Care System","volume":"8","author":"Jinadatha","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/emph\/eoac010","article-title":"Mutation rate of SARS-CoV-2 and emergence of mutators during experimental evolution","volume":"10","author":"Amicone","year":"2022","journal-title":"Evol. Med. Public Health"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9733","DOI":"10.1128\/JVI.00694-10","article-title":"Viral mutation rates","volume":"84","author":"Sanjuan","year":"2010","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.molcel.2020.07.027","article-title":"Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting","volume":"79","author":"Robson","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics","volume":"2","author":"Perelson","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801","volume":"591","author":"Wahl","year":"2021","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e01031-17","DOI":"10.1128\/JVI.01031-17","article-title":"Complexities of Viral Mutation Rates","volume":"92","author":"Peck","year":"2018","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100029","DOI":"10.1016\/j.cellin.2022.100029","article-title":"Emerging SARS-CoV-2 variants: Why, how, and what\u2019s next?","volume":"1","author":"Chen","year":"2022","journal-title":"Cell Insight"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pfeiffer, J.K., and Kirkegaard, K. (2005). Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog., 1.","DOI":"10.1371\/journal.ppat.0010011"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"Vignuzzi","year":"2006","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Miteva, D., Kitanova, M., Batselova, H., Lazova, S., Chervenkov, L., Peshevska-Sekulovska, M., Sekulovski, M., Gulinac, M., Vasilev, G.V., and Tomov, L. (2023). The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice. Vaccines, 11.","DOI":"10.3390\/vaccines11071181"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1080\/22221751.2020.1773745","article-title":"Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries","volume":"9","author":"Yang","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jmv.27331","article-title":"Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States","volume":"94","author":"Wang","year":"2022","journal-title":"J. Med. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/3\/337\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:02:56Z","timestamp":1760104976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/16\/3\/337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["v16030337"],"URL":"https:\/\/doi.org\/10.3390\/v16030337","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}